Abstract
Antimicrobial peptides (AMPs) are an heterogeneous group of small amino acidic molecules produced by the innate immune system of a variety of organisms encompassing all orders of life from eukaryotes to amphibians, insects and plants. Numerous AMPs have been isolated from natural sources and many others have been de novo designed and synthetically produced. AMPs have antimicrobial activity in the micromolar range and compared with traditional antibiotics, they kill bacteria very rapidly. They act, principally, by the electrostatic attraction to negatively charged bacterial cells and consequently membrane disruption, but their antibacterial activity may also involve interference with metabolic processes or different cytoplasmic targets. AMPs are a group of unique and incredible compounds that may be directed to a therapeutic use either alone or in combination with existing antibiotics.
Keywords: Amphipathic α-helical peptides, antimicrobial peptide, conformational flexibility, multidrug-resistant strain.
Current Medicinal Chemistry
Title:Antimicrobial Peptides as an Opportunity Against Bacterial Diseases
Volume: 22 Issue: 14
Author(s): Stefania Galdiero, Annarita Falanga, Rita Berisio, Paolo Grieco, Giancarlo Morelli and Massimiliano Galdiero
Affiliation:
Keywords: Amphipathic α-helical peptides, antimicrobial peptide, conformational flexibility, multidrug-resistant strain.
Abstract: Antimicrobial peptides (AMPs) are an heterogeneous group of small amino acidic molecules produced by the innate immune system of a variety of organisms encompassing all orders of life from eukaryotes to amphibians, insects and plants. Numerous AMPs have been isolated from natural sources and many others have been de novo designed and synthetically produced. AMPs have antimicrobial activity in the micromolar range and compared with traditional antibiotics, they kill bacteria very rapidly. They act, principally, by the electrostatic attraction to negatively charged bacterial cells and consequently membrane disruption, but their antibacterial activity may also involve interference with metabolic processes or different cytoplasmic targets. AMPs are a group of unique and incredible compounds that may be directed to a therapeutic use either alone or in combination with existing antibiotics.
Export Options
About this article
Cite this article as:
Galdiero Stefania, Falanga Annarita, Berisio Rita, Grieco Paolo, Morelli Giancarlo and Galdiero Massimiliano, Antimicrobial Peptides as an Opportunity Against Bacterial Diseases, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150311145632
DOI https://dx.doi.org/10.2174/0929867322666150311145632 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic?
Current Medicinal Chemistry Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect
Current Drug Targets Erythropoietin and Wnt1 Govern Pathways of mTOR, Apaf-1, and XIAP in Inflammatory Microglia
Current Neurovascular Research Molecular Imaging of Vascular Inflammation
Current Pharmaceutical Design Frequency of bla<sub>IMP</sub> and bla<sub>SPM</sub> Metallo-β-Lactamase Genes among Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Isolates in Sari, North of Iran
Recent Advances in Anti-Infective Drug Discovery Does Cyclic Dependent Kinase 5 Play a Significant Role in Determination of Stroke Outcome? Possible Therapeutic Implications
Central Nervous System Agents in Medicinal Chemistry Harnessing the Capacity of Cell-Penetrating Peptides for Drug Delivery to the Central Nervous System
Current Pharmaceutical Biotechnology Ethnopharmacological and Phytopharmaceutical Evaluation of Prosopis cineraria: An Overview and Future Prospects
Current Drug Metabolism RNA as a Drug Target: Recent Patents on the Catalytic Activity of Trans- Splicing Ribozymes Derived from Group I Intron RNA
Recent Patents on DNA & Gene Sequences Recent Patents on Development of Nucleic Acid-based Antiviral Drugs against Seasonal and Pandemic Influenza Virus Infections
Recent Patents on Anti-Infective Drug Discovery Pharmacological Treatment of Obstructive Sleep Apnea
Current Pharmaceutical Design Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Corneal Neovascularization: Molecular Events and Therapeutic Options
Recent Patents on Inflammation & Allergy Drug Discovery Taurine and the Relevance of Supplementation in Humans, in Health and Disease
Current Nutrition & Food Science Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science Recent Developments in Therapeutic Approaches for Lysosomal Storage Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Tobacco, Inflammation, and Respiratory Tract Cancer
Current Pharmaceutical Design Chemistry of Natural Retinoids and Carotenoids: Challenges for the Future
Current Organic Synthesis Molecular Imaging and Targeted Drug Delivery Using Albumin-Based Nanoparticles
Current Pharmaceutical Design Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine